Compare BRCC & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRCC | CRBU |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.1M | 145.8M |
| IPO Year | 2022 | 2021 |
| Metric | BRCC | CRBU |
|---|---|---|
| Price | $0.85 | $1.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.25 | ★ $10.75 |
| AVG Volume (30 Days) | 892.0K | ★ 1.3M |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.64 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $398,263,000.00 | N/A |
| Revenue This Year | $9.68 | $1.63 |
| Revenue Next Year | $9.59 | $10.93 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.73 | N/A |
| 52 Week Low | $0.60 | $1.38 |
| 52 Week High | $1.86 | $3.53 |
| Indicator | BRCC | CRBU |
|---|---|---|
| Relative Strength Index (RSI) | 29.70 | 53.80 |
| Support Level | $0.66 | $1.40 |
| Resistance Level | $1.34 | $1.77 |
| Average True Range (ATR) | 0.11 | 0.07 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 0.51 | 93.37 |
BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. It is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. Its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.